Circulating Tumor Cells and Metabolic Parameters in NSCLC Patients Treated with Checkpoint Inhibitors.

Cancers (Basel) · 2020 · PMC7072667 · PMID 32092983

Europe PMC DOI

hedged sentence

0.0760

closest p · 1.5× alpha

0.0760

boldest claim

The sentences

showed a trendp = 0.076so close (0.05 < p ≤ 0.1)

We found that patients with PD showed a trend toward higher baseline CTC count (26 ± 36) compared with patients with partial response (14 ± 14) or stable disease (9 ± 26) ( p = 0.076).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.